Akoya Biosciences (AKYA): Utang-utang marang kapitalisasi buku

Akoya Biosciences (AKYA) synthesizes its own reagents, purchasing only basic optics and chips. Revenue is generated through the supply of spatial biology systems to R&D centers and institutes. Monitoring of borrowed funds relative to equity demonstrates current leverage, where the 0.00 mark reflects the latest data. Growth is driven by demand for PhenoCycler platforms, bringing the company closer to operating profit.

AKYA Rasio utang marang nilai buku Akoya Biosciences Inc (04.07.2022 - 19.07.2025)

Ringkesan rincian data analitis akoyabio.com (AKYA)

- rega lan prakiraan konsensus rega:

Rega saham Akoya Biosciences, Inc.|AKYA - Prakiraan konsensus analis

- data kapitalisasi pasar:

Kapitalisasi pasar AKYA|AKYA - Nilai Perusahaan Nalika Diakuisisi Penuh

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Akoya Biosciences|AKYA - Kapitalisasi Akuntansi|Rasio Nilai Pasar marang Nilai Buku akoyabio.com|AKYA - Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas Akoya Biosciences|AKYA - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Akoya Biosciences, Inc.|AKYA - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku AKYA

Analisis fundamental perusahaan:Akoya

To minimize credit risks, Akoya Biosciences (AKYA) must monitor the stability of its capital structure. This ratio compares total liabilities to the total value of assets minus liabilities. By analyzing the share of debt financing within the balance sheet capitalization, an investor determines the business's degree of dependence on borrowed funds. A decrease in this metric confirms strengthening solvency. For Akoya Biosciences, this is critical during prolonged equipment procurement cycles, ensuring the preservation of margins through available liquidity.

Pesaing Akoya Biosciences

Utang-utang marang kapitalisasi buku ABT (Abbott Laboratories)|Utang-utang marang kapitalisasi buku thermofisher.com TMO|Utang-utang marang kapitalisasi buku GEHC|MTD: Utang marang aset resik|Rasio utang marang kapitalisasi buku Waters Corp.|TECH (Bio-Techne Inc.) - Rasio utang marang nilai buku|Rasio utang marang kapitalisasi buku BRKR (Bruker Corporation)|Utang-utang marang nilai buku AZTA|VREX (Varex Imaging Corporation) - Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik Semler Scientific Inc SMLR|Utang marang nilai buku Butterfly iQ (BFLY)|Utang marang modal buku Mesa Laboratories Corp. MLAB|Utang-utang marang kapitalisasi buku QSI (Quantum-Si)|NNOX - Utang-utang marang aset resik|QTRX (Quanterix) - Utang-utang marang kapitalisasi buku|Utang marang nilai buku 908 Devices Inc|CV - Utang marang nilai buku|Rasio utang marang aset resik MXCT|Rasio utang marang kapitalisasi buku RPID (Rapid Micro Biosystems)|Utang marang nilai buku seer.bio (SEER)|HYPR: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku FONAR Corp. FONR|Daxor Corp. (DXR) - Utang-utang marang kapitalisasi buku|MDAI - Rasio utang marang nilai buku|organovo.com - Utang-utang marang kapitalisasi buku|aclarion.com (ACON) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku THMO|Utang marang nilai buku Talis Biomedical Corp|Utang-utang marang kapitalisasi buku TTOO